SARS-CoV-2 IgG检测与RT-PCR联合应用改善COVID-19诊断
本研究回顾性分析70例COVID-19患者的206份RT-PCR阳性样本,评估ARCHITECT® SARS-CoV-2 IgG检测的敏感性,并采用RT-PCR阴性、COVID-19无关及日本红十字会的样本评估特异性。结果显示IgG检测敏感性在症状出现后逐日升高,10天后超过84.4%,特异性在98.2%至100%之间;联合RT-PCR可提高实验室诊断的稳健性。
要点
- IgG检测敏感性在症状出现10天后超过84.4%。
- 特异性在三个对照组中为98.2%至100%。
- 联合RT-PCR与IgG检测可互补不足,提高诊断稳健性。
核心结论
- 联合RT-PCR和IgG检测可通过弥补各自局限性提高实验室诊断的稳健性。
研究设计与样本
- 回顾性研究,纳入东京两家医院70例COVID-19患者的206份RT-PCR阳性样本分析敏感性,并使用RT-PCR阴性(N=166)、COVID-19无关(N=418)及日本红十字会(N=100)样本评估特异性。
主要发现
- IgG检测敏感性在症状出现后逐日升高,10天后超过84.4%。
- 特异性在三个对照组样本中范围为98.2%至100%。
- 32例有多次样本的COVID-19病例中18例在症状出现后9至20天确认血清转换,另1例首次可用样本IgG检测即阳性。
关键数值与推荐
- IgG检测敏感性在症状出现10天后超过84.4%。
- 特异性在RT-PCR阴性、COVID-19无关及日本红十字会样本中分别为98.2%至100%。
临床怎么用
- 在RT-PCR检测敏感性下降的情况下,联合IgG检测可提高COVID-19诊断的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is generally diagnosed by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (approximately 80%). We evaluated the performance of the ARCHITECT® SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the combination of RT-PCR and the IgG assay for COVID-19 diagnosis. METHODS: In this retrospective study, 206 samples from 70 COVID-19 cases at two hospitals in Tokyo that were positive using RT-PCR were used to analyze the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Red Cross Society (N=100) samples were used to evaluate specificity. RESULTS: Sensitivity increased daily after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case groups. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 cases with multiple samples and from another case with a positive result in the IgG assay for the first available sample. CONCLUSIONS: The combination of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the limitations of each method.
引用
- Aoki K, Takai K, Nagasawa T, et al. Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis. Ann Lab Med. 2021. PMID: 34108284. doi:10.3343/alm.2021.41.6.568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。